StockReport.com is a 7:00 PM newsletter with a pertinent stock report every day, plus the lates market news.
ResMed (NYSE: RMD) is a global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions. Founded in 1989, the company is headquartered in San Diego, California, and develops, manufactures and distributes a range of devices and software used by patients, clinicians and providers worldwide.
ResMed’s product portfolio centers on noninvasive ventilation and sleep therapy equipment, including continuous positive airway pressure (CPAP) and bilevel devices, masks and related accessories for the treatment of obstructive sleep apnea and other respiratory disorders. The company also supplies ventilators and respiratory care solutions for use in both home and clinical settings. Complementing its hardware, ResMed offers cloud-based software platforms and patient engagement tools that enable remote monitoring, data analytics and care management for healthcare professionals and homecare providers.
ResMed serves a broad global market, including sleep clinics, hospitals, home healthcare providers and individual patients across North America, Europe, Asia-Pacific and other regions. The company emphasizes research and development, regulatory compliance and partnerships with healthcare stakeholders to expand access to diagnosis and long-term management of respiratory conditions.
ResMed is led by President and Chief Executive Officer Michael J. “Mick” Farrell and maintains a strategic focus on integrating digital health and connectivity with its device offerings to improve therapy adherence, enable remote care delivery and support value-based models for chronic respiratory disease management.
After several hectic months, the acquisition saga surrounding Warner Bros. Discovery (NASDAQ: WBD) has come to what appears to be a resolution. Paramount Skydance (NASDAQ: PSKY) upped its bid for the entire company to $31 per share in February and altered key terms of its deal to assuage Warner Br...
Chevron Corporation (NYSE: CVX) has quietly become one of the strongest performing mega-cap stocks in recent weeks. Shares hit a fresh all-time high in mid-March, adding to a rally that has lifted the stock nearly 30% in 2026 and pushed it firmly back into the spotlight for investors. Much of the...
Evolv Technologies Inc. (NASDAQ: EVLV) is a leader in AI weapons/gun/concealed weapon detection. The company delivered its fourth-quarter earnings report after the market closed on March 10. The results were solid, starting with a double beat on the top and bottom lines. Revenue for the quarter...
FuelCell Energy (NASDAQ: FCEL) has potentially game-changing technology for co-located energy, but it has yet to prove its leadership position. If anything, its results reflect the industry's hurdles, which include high costs, inefficiency relative to other power generation techniques, and the ...